Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- SJP to Organize Periodical Seminars on Regulatory Affairs
August 21, 2006
- MEDICAL DEVICE NEWS IN BRIEF
August 21, 2006
- REGULATORY NEWS IN BRIEF
August 21, 2006
- Gov't-Administered Health Insurance to Return to Deficit in FY2006
August 21, 2006
- SELF-MEDICATION NEWS IN BRIEF
August 21, 2006
- Kenporen Member Societies Report Surplus 3 Years in a Row in FY2005
August 21, 2006
- New Antibody Manufacturing Technology Established: Chiome Bioscience
August 21, 2006
- Korosho to Review Its Gastric Cancer Detection Program
August 21, 2006
- SymBio Initiates PI Clinical Trial of Bendamustine
August 21, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 21, 2006
- Actual R&D Tax Reduction Rate Was Only 7.3% in FY2005: JPMA
August 21, 2006
- DSP to Place Top Priority on Domestic Infrastructure in Mid-Term Plan
August 21, 2006
- SEMIANR Micardis Improves Insulin-Resistant Hypertension
August 21, 2006
- Santen Aims for Global Business Development in FY2006-2010 Management Plan
August 7, 2006
- DSP, BMKK Enter Agreements for Hypertension, Cancer Treatments
August 7, 2006
- Meiji Seika Licenses Non-steroidal Compounds to US Company
August 7, 2006
- 24 Products Currently in Vaccine Pipeline: GSK
August 7, 2006
- Eisai, Solvay Announce License Agreement for SA-001
August 7, 2006
- Wyeth Focuses on Developing 2nd-Generation Pneumococcal Vaccine
August 7, 2006
- New Laws Shorten "Drug Lag" in China: Mr Kosaku of CMIC
August 7, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…